Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Summit highlights

      On 22 March 2018, Action on Hearing Loss, in partnership with the UCL-Ear Institute and the NIHR UCLH BRC Deafness and Hearing Loss theme, hosted the Translation Hearing Research Summit: Biological and Pharmacological Approaches in London. It was a huge success!

      We brought together 159 experts from 14 different countries to discuss strategies to accelerate the development of treatments for hearing loss and tinnitus. Stakeholders involved in different stages of the development of treatments for hearing loss and tinnitus had the opportunity to meet, discuss and establish collaborations to accelerate the progression of treatments.

      71 experts were from leading universities, 49 from biotechnology and pharmaceutical companies, 18 were clinicians and 21 were patients, investors and funders.

      Watch the video below and find out more about this exciting event and about what Dr Steven Holtzman, President & CEO of Decibel Therapeutics; Hugh Strickland, Corporate Finance Partner at Aaron & Partners, who has hereditary hearing loss, and Dr Ralph Holme, Executive Director of Research at Action on Hearing Loss, thought about this event.